Toll Free: 1-888-928-9744

Serum Institute of India Limited - Product Pipeline Review - 2014

Published: Jul, 2014 | Pages: 37 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Serum Institute of India Limited - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Serum Institute of India Limited - Product Pipeline Review - 2014', provides an overview of the Serum Institute of India Limited's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Serum Institute of India Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Serum Institute of India Limited including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Serum Institute of India Limited's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Serum Institute of India Limited's pipeline products

Reasons to buy

- Evaluate Serum Institute of India Limited's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Serum Institute of India Limited in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Serum Institute of India Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Serum Institute of India Limited and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Serum Institute of India Limited
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Serum Institute of India Limited and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Serum Institute of India Limited Snapshot 5
Serum Institute of India Limited Overview 5
Key Information 5
Key Facts 5
Serum Institute of India Limited - Research and Development Overview 6
Key Therapeutic Areas 6
Serum Institute of India Limited - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Serum Institute of India Limited - Pipeline Products Glance 12
Serum Institute of India Limited - Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
Serum Institute of India Limited - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Serum Institute of India Limited - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Serum Institute of India Limited - Unknown Stage Pipeline Products 17
Unknown Products/Combination Treatment Modalities 17
Serum Institute of India Limited - Drug Profiles 18
Rotavirus Vaccine 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
ErepoXen 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Measles Vaccine 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
SIILPCV-10 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Conjugate Vaccine for Meningitis 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
DTaP Vaccine 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Bladder Cancer Vaccine 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
pneumococcal polysaccharide conjugate vaccine 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Serum Institute of India Limited - Pipeline Analysis 27
Serum Institute of India Limited - Pipeline Products by Target 27
Serum Institute of India Limited - Pipeline Products by Route of Administration 28
Serum Institute of India Limited - Pipeline Products by Molecule Type 29
Serum Institute of India Limited - Pipeline Products by Mechanism of Action 30
Serum Institute of India Limited - Recent Pipeline Updates 31
Serum Institute of India Limited - Dormant Projects 33
Serum Institute of India Limited - Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Appendix 36
Methodology 36
Coverage 36
Secondary Research 36
Primary Research 36
Expert Panel Validation 36
Contact Us 37
Disclaimer 37
List of Tables
Serum Institute of India Limited, Key Information 5
Serum Institute of India Limited, Key Facts 5
Serum Institute of India Limited - Pipeline by Indication, 2014 7
Serum Institute of India Limited - Pipeline by Stage of Development, 2014 8
Serum Institute of India Limited - Monotherapy Products in Pipeline, 2014 9
Serum Institute of India Limited - Partnered Products in Pipeline, 2014 10
Serum Institute of India Limited - Partnered Products/ Combination Treatment Modalities, 2014 11
Serum Institute of India Limited - Phase III, 2014 12
Serum Institute of India Limited - Phase II, 2014 13
Serum Institute of India Limited - Phase I, 2014 14
Serum Institute of India Limited - Preclinical, 2014 15
Serum Institute of India Limited - Discovery, 2014 16
Serum Institute of India Limited - Unknown, 2014 17
Serum Institute of India Limited - Pipeline by Target, 2014 27
Serum Institute of India Limited - Pipeline by Route of Administration, 2014 28
Serum Institute of India Limited - Pipeline by Molecule Type, 2014 29
Serum Institute of India Limited - Pipeline Products by Mechanism of Action, 2014 30
Serum Institute of India Limited - Recent Pipeline Updates, 2014 31
Serum Institute of India Limited - Dormant Developmental Projects,2014 33
Serum Institute of India Limited, Other Locations 34 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify